Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. 1998

V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport

UI MeSH Term Description Entries
D003457 Cryptosporidiosis Intestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA. Cryptosporidium Infection,Cryptosporidioses,Cryptosporidium Infections,Infection, Cryptosporidium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016785 Cryptosporidium parvum A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction. Cryptosporidium parvums,parvum, Cryptosporidium
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
January 2008, Medicina,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
June 1998, British journal of haematology,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
March 1993, European journal of epidemiology,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
January 2002, Journal of postgraduate medicine,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
August 2005, Journal of the National Medical Association,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
January 2005, The Southeast Asian journal of tropical medicine and public health,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
January 1998, Mycoses,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
October 2007, The Journal of antimicrobial chemotherapy,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
June 2000, Medicina clinica,
V Le Moing, and F Bissuel, and D Costagliola, and Z Eid, and F Chapuis, and J M Molina, and D Salmon-Ceron, and P Brasseur, and C Leport
August 1997, The Journal of the American Osteopathic Association,
Copied contents to your clipboard!